Abstract
WCN23-0681 Efficacy and safety of sucroferric oxyhydroxide vs sevelamer carbonate in Chinese dialysis patients with hyperphosphataemia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.ekir.2023.02.104
Copy DOIJournal: Kidney International Reports | Publication Date: Mar 1, 2023 |
License type: cc-by-nc-nd |
WCN23-0681 Efficacy and safety of sucroferric oxyhydroxide vs sevelamer carbonate in Chinese dialysis patients with hyperphosphataemia
Join us for a 30 min session where you can share your feedback and ask us any queries you have